The import of Antisera and Other Blood Fractions to Germany demonstrates a consistent upward trend from 2024 to 2028. Based on the forecasted data, starting at 22.417 billion USD in 2024 and steadily increasing to 24.729 billion USD by 2028, the imports show a positive year-on-year growth trajectory. This reflects an annual growth rate with a CAGR of approximately 2.52% over these five years.

Future trends to watch for include:

Technological advancements in medical treatments and diagnostics that could increase demand.
Regulatory changes within the European Union impacting import regulations or costs.
Global market dynamics, including shifts in pharmaceutical supply chains or geopolitical factors.